logo

Enter Symbol

INVACARE C(NYSE:IVC)
Invacare Corporation is the world''s leading manufacturer and distributor ofnon-acute health care products based upon its distribution channels, the breadth of its product line and sales. The company designs, manufactures and distributes an extensive line of health care products for the non-acute care environment including the home health care, retail and extended care markets. The company''s products are sold through its world-wide distribution network byits sales force, telemarketing employees and various organizations of independent manufacturer''s representatives.
# Employees: 6100
Address: One Invacare Way P.O. Box 4028,Elyria,OH,USA
Phone: 440 329-6000
Fax: 440 366-9008
Website: www.invacare.com
Email: investorrelations@invacare.com
Sector: Medical
Industry: MED/DENTAL-SUPP
Executive Officers
Malachi A. Mixon III (Chmn.; C.E.O.; Dir.)
Gerald B. Blouch (Presi.; C.O.O.; Dir.)
Gregory C. Thompson (Sr. V.P.; C.E.O.)
Joseph C. Usaj (Sr. V.P. Human Resources)
Louis F. J. Slangen (Sr. V.P. Global Mkt. Develop.,)
Dividend
Ex-Dividend Date: 10/1/2009
Annual Dividend: $0.05
Current Dividend Yield: $0.20
Dividend Paid (3 months): $0.01
Indicated Dividend: $0.03
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 1/28/2010
Mean EPS (Next Qtr): $0.58
Mean EPS (Year): $1.49
Mean Estimate(Long Term): ($0.01)
P/E Ratio(Based on EPS estimate): 16.410
Number of Estimates: 3
Shares Performance
Period IVC Compare to S&P
YTD 57.92 % 30.69 %
4 Weeks 9.27 % 3.74 %
12 Weeks 12.02 % 4.31 %
Shares Information
Analyst Coverage: Y
Avg Volume: 177570
Shares Outstanding: 31M
Market Cap: $0.76B
52 Week High: $25.48
52 Week Low: $13.66
P/E Ratio: 15.810
PEG Ratio: -0.010
Split: On 10/17/1995 IVC split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: 73.33 %
EPS Growth in Last Year: 23.81 %
Sales Growth in Last Quarter: 5.21 %
Sales Growth in Last Quarter: -6.02 %
Financials
Qtr Book Value: $1.16
Cash Flow/Share: $8.76
Change in Payout Ratio: 0.000
Price/Sales: 0.450
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia